Abstract:Drug derived from simplest and commercially available moieties such as ethylacetoacetate, hydrazine, malonitrile, aldehyde derivatives is advantageous to achieve the mono‐ and bis‐pyranopyrazole derivatives with the good yield and purity. Potent drugs can be chemically prepared by the condensation and Micheal addition reaction under green, catalyst free, solvent free conditions to depict an excellent inhibition potention against diseases. Structure‐activity relationship of the target molecules also showed significance of active substituents such as methoxy, halogen and nitro groups in drug moieties for the further improvement of medicinal drugs. Recent Synthesis of Mono‐ & Bis‐Pyranopyrazole Derivatives. Pyranopyrazole is an important structural unit in heterocyclic chemistry and is useful in pharmaceutical and agrochemical industries. The pyranopyrazole‐based compounds are known in the agricultural industry as herbicides, fungicides, and insecticide agents and in medicinal fields as antimicrobial, anticancer, and antiHIV agents. Despite its wide range of applications, the synthesis of pyranopyrazole has several limitations such as the cost of reagents, potential environmental risks, harsh reaction conditions, longer reaction times, laborious workup procedures, and unsatisfactory yields. However, many studies have been recently reported on the synthesis of pyranopyrazoles using mild, green, and environmentally friendly methods that also give higher yields. Different catalysts and conditions have been reported for the synthesis of pyranopyrazole using four, three, and two components. Among these, four‐component synthesis is commonly reported by using benzaldehyde, hydrazine derivatives, ethyl acetoacetate and malononitrile due to the commercial availability and stability of the reagents. This review summarized the recent synthesis of pyranopyrazole i. e., mono‐ and bis‐pyranopyrazole derivatives via four‐, three‐ and two‐component‐based reactions. Mono‐ and bis‐pyranopyrazole derivatives varied due to the number of pyranopyrazole units that contributed to play an important role in increasing the binding interaction and biological activities beneficial for pharmaceutical industries.

Exploitation of pyrazole C-3/5 carbaldehydes towards the development of therapeutically valuable scaffolds: a review

Innovative Pyrazole Hybrids: A New Era in Drug Discovery and Synthesis

Therapeutic Potential of Pyrazole Containing Compounds: an Updated Review

Methyl-linked Pyrazoles: Synthetic and Medicinal Perspective

Review on advancements of pyranopyrazole: synthetic routes and their medicinal applications

A close look into the biological and synthetic aspects of fused pyrazole derivatives

Medicinal Chemistry & Drug Discovery

A critical review on recent trends on pharmacological applications of pyrazolone endowed derivatives

Advances in Pyridine C – H Functionalizations: Beyond C2 Selectivity

Synthetic Update on Antimicrobial Potential of Novel Pyrazole Derivatives: A Review

Therapeutic Potential of Natural Metabolites Coupled Pyrazole and Its Bio‐Isosteres: Medicinal Perspectives and SAR Studies

Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5- a]pyrimidine scaffold

Insight into the therapeutic potential of pyrazole‐thiazole hybrids: A comprehensive review

Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery

Synthesis of Pyrazoline Derivatives and Their Pharmacological Activities: A Review of the Last Decade

Convenient One‐Pot Synthesis and Biological Evaluation of New 3,5‐Dimethyl‐1H‐pyrazole‐1‐carbothiohydrazide Derivatives as Anti‐Tumor Agents

Pyrazolone: a Powerful Synthon for Asymmetric Diverse Derivatizations

Recent Advances in the Applications of Pyrazolone Derivatives in Enantioselective Synthesis.

Advances in the Synthesis of 3‐Acyl‐2‐Pyridones: Strategies and Methods for Accessing the Versatile Scaffold

Pyridine: the scaffolds with significant clinical diversity

Synthesis and Chemistry of 5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-a] [1,4]Diazepine-2-Carboxylates.